GRANTED, LOW PRESSURE SODIUM IS A MONOCHROMATIC SOURCE AND IS OFTEN REJECTED FOR ITS DEFICIENCY IN SUPPORTING color. But DESIGNERS SHOULD TAKE A SECOND LOOK AT WHAT ELSE IT HAS TO OFFER
Get full access to this article
View all access options for this article.
References
1.
ReaMS (ed.). 2000. IESNA Lighting Handbook, 9th ed. New York, NY: Illuminating Engineering Society of North America.
2.
Commission Internationale de 1'Eclairage. 1978. Light as a True Visual Quantity.Paris: Commission Internationale de 1'Eclairage.
3.
SmithSW, ReaMS. 1980. Relationships between office task performance and ratings of feelings and task evaluations under different light sources and levels. Proc. CIE, 19th Sess., Kyoto, 1979.
4.
EloholmaHP, HalonenL, KetomakiJ.1999. The effects of light spectrum on visual performance at mesopic light levels. Proc. CIE Symposium: 75 Years of CIE Photometry, Budapest, September 30-October 2.
5.
HeY, ReaMS, BiermanA, BulloughJD.1997. Evaluating light source efficacy under mesopic conditions using reaction times. J. Ilium. Eng. Soc.26(1): 125–138.
6.
ReaMS, BulloughJD, FreyssinierJP, BiermanA.2004. A proposed unified system of photometry. Lighting Res. Technol.36(2): 85–111.
7.
LewinI. 2000. Visibility factors in outdoor lighting design (part 2). Lighting J. (Jan./Feb.): 34–39.
8.
MeansRS, Inc. 2001. Means Electrical Cost Data.Kingston: RS Means, Inc.
9.
LeslieRP. 1998. A simple cost estimation technique for improving the appearance and security of outdoor lighting installations. Build. Environ.33(2-3): 79–95.
10.
BulloughJD, Van DerlofskeJ.2003. Shedding light on glare. Opt. Eng. Mag.3(6): 17–18.
11.
FigueiroMG. 2004. Research matters: Light at night–will it kill us?Lighting Des.Appl.34(5): 12–13.
12.
HrusheskyWjm. 2001. Tumor chronobiology. J. Controlled Release74: 27–30.
13.
BlaskDE, SauerLA, DauchyRT. 2002. Melatonin as a chronobiotic/anticancer agent: Cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr. Top. Med. Chem.2(2): 113–132.
14.
SchernhammerE, SchulmeisterK.2004. Light at night and cancer risk. photochem. Photobiol.79(4): 316–318.
15.
BrainardGC, HanifinJP, GreesonJM, ByrneB, GlickmanG, GernerE, RollagMD. 2001. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J. Neurosci.21(16): 6405–6412.
16.
ThapanK, ArendtJ, SkeneDJ. 2001. An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J. Physiol.535(Pt. 1): 261–267.
17.
ReaMS, BulloughJD, FigueiroMG. 2001. Human melatonin suppression by light: A case for scotopic efficiency. Neurosci. Lett.299(12): 45–48.
18.
ReaMS, BulloughJD, FigueiroMG.2002. Phototransduction for human melatonin suppression. J. Pineal Res.32(4): 209–213.
19.
FigueiroMG, BulloughJD.ParsonsRH, ReaMS. 2004. Preliminary evidence for spectral opponency in the suppression of melatonin by light in humans. NeuroReport15(2): 313–316.
20.
SchoemakerPjh. 2003. Reinventing the future. Bridges in Light Symp. Saratoga Springs, October 22 (www.bridgesinlight.org).
